State of New Jersey Common Pension Fund D’s Rapport Therapeutics RAPP Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio RAPP Stock Details RAPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Buy	+9,773	New	+$275K	﹤0.01%	1502

Other funds holding RAPP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGV

TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

State of New Jersey Common Pension Fund D's RAPP Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Rapport Therapeutics (RAPP) in Q1 2026: 9,773 shares worth $306K. The stake represents ﹤0.01% of the portfolio and ranks #1502 among its holdings.

147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

State of New Jersey Common Pension Fund D held 9,773 shares of Rapport Therapeutics worth $306K as of Q1 2026.
Rapport Therapeutics was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Rapport Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1502 holding.
147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.